On December 7, 2023, the Biden administration announced a blueprint for a framework that may be a tough pill to swallow for the pharmaceutical industry. This framework suggests that drug prices should be a crucial factor in...more
12/12/2023
/ Bayh-Dole Act ,
Biden Administration ,
Drug Pricing ,
Food & Drug Regulations ,
Healthcare ,
Healthcare Reform ,
Inventions ,
Life Sciences ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
R&D ,
Regulatory Agenda ,
Research and Development